Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Idorsia Ltd is reaching out for more – We have more ideas, we see more opportunities and we want to help more patients. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical
Salary Range:CHF169,400.00 - CHF314,600.00 Job Description SummaryTake on a high impact opportunity where your leadership can help advance patient safety and improve outcomes across some of the world’s most significant cardiovascular, renal and metabolic diseases. As
# Associate Safety Director/Senior Safety ScientistCandidatar-selocations: Basel: Welwyntime type: Tempo integralposted on: Publicado hojejob requisition id: Na Roche, você pode-se apresentar como você mesmo, abraçado pelas qualidades únicas que traz. Nossa cultura incentiva a expressão pessoal, o
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Associate Safety Director (m/f/d) (LSW)- Drug safety/pharmacovigilance/ English Background: Portfolio Safety Scientists (PCS-Sci) provide safety science and pharmacovigilance support to molecules across the Roche portfolio. As a group, they are responsible for all aspects of safety science/pharmacovigilance,
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Main Responsibilities: Develop and maintain expert knowledge of product safety profiles, disease contexts, competitor safety data, and mechanisms of action Lead medical reviews for individual case safety reports (ICSR) and aggregate reporting (DSUR, PBRER), including responses